Skip to main content
. Author manuscript; available in PMC: 2022 Jun 10.
Published in final edited form as: NEJM Evid. 2022 Apr 11;1(5):EVIDoa2100056. doi: 10.1056/EVIDoa2100056

Figure 1: Randomized trial profile.

Figure 1:

*of the 419 people who were ineligible for randomization, 132 (16%) had a positive pregnancy test, 51 (6%) were not willing to follow study procedures or be randomized, 34 (4%) had a positive rapid HIV diagnostic test, and 172 (21%) met other exclusion criteria.

**Complete baseline data includes HPV antibody results at month 0 and HPV DNA results at month 0 and month 3.